National Drug Strategy
National Drug Strategy

Development of the National Drug Strategy 2010-2015

Print page  Decrease text size  Increase text size


Second round of consultations

The Ministerial Council on Drug Strategy (MCDS) released a draft of the National Drug Strategy 2010-2015 on 18 November 2010. The Australian Government and all state and territory jurisdictions endorsed the draft with the exception of Victoria which was unable to agree to the release of this draft prior to the calling of that state's election and going into caretaker government.

The draft strategy was developed based on an evaluation of the previous strategy and the first consultation process. Submissions on the draft National Drug Strategy 2010-2015 closed on Friday 10 December 2010.

Draft National Drug Strategy 2010-2015

View published submissions

In addition, a roundtable was held in Canberra to obtain key stakeholders' views on the draft strategy:

First round of consultations

The first round of public consultations commenced in December 2009 with the release of a consultation paper and a public submission process. It was completed in April 2010 with stakeholder roundtables.

The consultation paper was prepared on behalf of the MCDS by the Intergovernmental Committee on Drugs National Drug Strategy Development Working Group. The paper identified emerging issues and sought input from expert stakeholders and the broader community on directions for the next phase of the National Drug Strategy 2010-2015. Submissions were received in response to the consultation paper.

Consultation paper - Australia's National Drug Strategy beyond 2009

Public submissions (previous round of public consultations)

In addition, three roundtables were held in Sydney, Melbourne and Adelaide to obtain key stakeholders' views on directions for the strategy.

Evaluation of the National Drug Strategy

The National Drug Strategy 2004-2009 was evaluated by independent experts under the auspices of the Ministerial Council on Drug Strategy. The evaluation found that the strategy and its three pillars of supply, demand and harm reduction are fundamentally sound and have been vital to the success of the strategy in reducing the prevalence of, and harms from, drug use in Australia over a long period.

Evaluation report - Evaluation and monitoring of the National Drug Strategy 2004-2009

Page currency, Latest update: 04 April, 2013